As Covid-19 vaccines start to receive emergency approvals, the race is on to distribute the one product that billions of people across the world will want. That’s creating investment opportunities as traders examine the companies involved in the global rollout.
With multiple vaccine types, the distribution chains involve hundreds of businesses—from airlines to makers of freezers, vials and disposable needles—and thousands of staff working to get shots from laboratory floors to the arms of populations around the world.
The world has never seen such a distribution puzzle: it’s been called the “largest and most complex logistical exercise ever.” Each of